Carbone et al. [27] reviewed the literature and stated that somatic variants of BAP1 were identified in 60–70% of mesotheliomas, 45% of uveal melanomas, 15% of renal cell carcinomas, and 5% of cutaneous melanomas. This evidence concerns the gene BAP1 and mesothelioma.